Efficacy and safety of cyclosporine a microemulsion in maintenance patients with chronic plaque psoriasis

Journal of Drugs in Dermatology, Nov, 2007

Sponsored by Novartis. The study will evaluate the efficacy of cyclosporine when administered twice a week compared to continuous administration in patients with chronic plaque psoriasis.

Condition                 Intervention          Phase

Chronic Plaque Psoriasis  Drug: cyclosporine A  Phase III
                            microemulsion

Study ID Numbers: COLO400CIT04

ClinicalTrials.gov Identifier: NCT00438360

COPYRIGHT 2007 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2007 Gale Group

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale